Where does NeuroQore's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across NeuroQore's 1 recorded funding rounds.

Premier Alternatives

NeuroQore

Mountain View, CA · Founded 2012 · Privately Held (backing)

Developer of neuromodulation treatment systems designed to address depressive disorder and suicidality. NeuroQore is based in Mountain View, CA and was founded in 2012. It was valued at $10.6 million at its seed round in Sep 2025, the last priced event on record. It has raised $1.7 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2025.

PMV mark · valuation

$10.6M

Oct 2026

Priced at

its seed round

Sep 2025

Total raised

$1.7M

Last round

Seed Round

Jul 2025

Cap table — not yet on record

NeuroQore's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of NeuroQore with a free account

·Watch NeuroQore: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about NeuroQore

Where does NeuroQore's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across NeuroQore's 1 recorded funding rounds.